Jefferies Reiterates Buy on Aratana Therapeutics (PETX) Following US Galliprant Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. NVDA
2. DOO
3. HD
4. AMLX
5. METC
6. SPY
7. ARGX
8. KLAR
9. INFQ

Go back to Jefferies Reiterates Buy on Aratana Therapeutics (PETX) Following US Galliprant Approval

Aratana Therapeutics (PETX) Announces Presentation of Pivotal Galliprant Data

March 31, 2016 9:05 AM EDT

Aratana Therapeutics, Inc. (NASDAQ: PETX) announced the Company plans to showcase Galliprant pivotal efficacy and safety data at the American Animal Hospital Association (AAHA) annual conference in Austin, Texas on Saturday, April 2, 2016 from 7:00 7:50 a.m. Lesley Rausch-Derra, DVM, MS, Vice President of Regulatory Affairs and... More